Podcast
From Platform to Product Development: Integra Therapeutics’ CEO on Scaling Gene Editing Innovation
Dr. Avencia Sánchez-Mejías is CEO and co-founder of Integra Therapeutics, a Barcelona-based biotech company developing next-generation gene-editing tools. With a background in molecular biology and clinical genetics, she brings over 15 years of experience in genetic therapy research across Europe,
18 November 2024
Stay ahead of trends and best practices
